Skip to main content
. 2013 Jun;29(5):480–487. doi: 10.1089/jop.2012.0198

Table 3.

Effects of BCACs on Serum Levels of AOPP of Patients with OAG (BCACs, n=19 and Placebo Groups, n=19)

 
AOPP (μmol/L)
Group 0 M 6 M 12 M 18 M 24 M
BCACs 16.12±7.50 16.24±7.86 16.16±8.49 16.19±8.04 16.23±11.04
Placebo 16.06±12.12 16.13±9.24 16.18±7.56 16.38±8.16 16.22±8.40

Values shown are mean±SD.

No statistical differences between groups (2-way repeated measures ANOVA) and inter-groups (paired t-test) were observed.